Profilo
Nithya Desikan is currently Director at Corium LLC, Director at Paratek Pharmaceuticals, Inc., and Operating Partner at Gurnet Point Capital LLC.
Former roles include Vice President at Biogen, Inc. from 2016 to 2017, Chief Commercial Officer at Rhythm Pharmaceuticals, Inc. from 2017 to 2020, and Operating Partner at B Flexion Advisors UK LLP from 2022 to 2026.
Education includes undergraduate studies at the University of Florida.
Posizioni attive di Nithya Desikan
| Società | Posizione | Inizio |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Direttore/Membro del Consiglio | - |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Investitore di Private Equity | - |
Precedenti posizioni note di Nithya Desikan
| Società | Posizione | Fine |
|---|---|---|
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Investitore di Private Equity | 01/06/2026 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30/09/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2017 |
Formazione di Nithya Desikan
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance B Flexion Advisors invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Finance |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
















